BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8720145)

  • 1. Tissue-type transglutaminase is not a tumor-related marker.
    Takaku K; Futamura M; Saitoh S; Takeuchi Y
    J Biochem; 1995 Dec; 118(6):1268-70. PubMed ID: 8720145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological characterization and activity of transglutaminases in human normal and malignant prostate and in prostate cancer cell lines.
    Friedrichs B; Riedmiller H; Goebel HW; Rausch U; Aumüller G
    Urol Res; 1995; 23(5):301-310. PubMed ID: 8839386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer.
    Davies G; Ablin RJ; Mason MD; Jiang WG
    J Exp Ther Oncol; 2007; 6(3):257-64. PubMed ID: 17552366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratinocyte transglutaminase expression varies in squamous cell carcinomas.
    Duvic M; Nelson DC; Annarella M; Cho M; Esgleyes-Ribot T; Remenyik E; Ulmer R; Rapini RP; Sacks PG; Clayman GL
    J Invest Dermatol; 1994 Apr; 102(4):462-9. PubMed ID: 7908683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate Transglutaminase (TGase-4) Induces Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells.
    Ablin RJ; Owen S; Jiang WG
    Anticancer Res; 2017 Feb; 37(2):481-487. PubMed ID: 28179293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogen peroxide mediates doxorubicin-induced transglutaminase 2 expression in PC-14 human lung cancer cell line.
    Han JA; Park SC
    Exp Mol Med; 1999 Jun; 31(2):83-8. PubMed ID: 10410307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and activity of transglutaminase II in spontaneous tumours of dogs and cats.
    Wakshlag JJ; McNeill CJ; Antonyak MA; Boehm JE; Fuji R; Balkman CE; Zgola M; Cerione RA; Page RL
    J Comp Pathol; 2006; 134(2-3):202-10. PubMed ID: 16615935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a transglutaminase expressed in human pancreatic adenocarcinoma cells.
    Elsässer HP; MacDonald R; Dienst M; Kern HF
    Eur J Cell Biol; 1993 Aug; 61(2):321-8. PubMed ID: 7901019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of tissue and epidermal transglutaminases in mouse epidermal cells after treatment with 12-O-tetradecanoylphorbol-13-acetate and/or retinoic acid in vivo and in culture.
    Lichti U; Yuspa SH
    Cancer Res; 1988 Jan; 48(1):74-81. PubMed ID: 2891434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.
    Park MK; You HJ; Lee HJ; Kang JH; Oh SH; Kim SY; Lee CH
    Eur J Cancer; 2013 May; 49(7):1692-705. PubMed ID: 23290789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of transglutaminase 2 drives glycolytic metabolism in renal carcinoma cells.
    Ku BM; Lee CH; Lee SH; Kim SY
    Amino Acids; 2014 Jun; 46(6):1527-36. PubMed ID: 24643363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of type I and type II transglutaminase in normal human bronchial epithelial and lung carcinoma cells.
    Vollberg TM; George MD; Nervi C; Jetten AM
    Am J Respir Cell Mol Biol; 1992 Jul; 7(1):10-8. PubMed ID: 1352692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel suppressive effects of cardamonin on the activity and expression of transglutaminase-2 lead to blocking the migration and invasion of cancer cells.
    Park MK; Jo SH; Lee HJ; Kang JH; Kim YR; Kim HJ; Lee EJ; Koh JY; Ahn KO; Jung KC; Oh SH; Kim SY; Lee CH
    Life Sci; 2013 Feb; 92(2):154-60. PubMed ID: 23201552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation.
    Kim DS; Park SS; Nam BH; Kim IH; Kim SY
    Cancer Res; 2006 Nov; 66(22):10936-43. PubMed ID: 17108131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta1 up-regulates transglutaminase two and fibronectin in dermal fibroblasts: a possible mechanism for the stabilization of tissue inflammation.
    Quan G; Choi JY; Lee DS; Lee SC
    Arch Dermatol Res; 2005 Aug; 297(2):84-90. PubMed ID: 16044258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo transglutaminase type 1 expression in normal lung, preinvasive bronchial lesions, and lung cancer.
    Martinet N; Bonnard L; Regnault V; Picard E; Burke L; Siat J; Grosdidier G; Martinet Y; Vignaud JM
    Am J Respir Cell Mol Biol; 2003 Apr; 28(4):428-35. PubMed ID: 12654631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level expression of the chemically synthesized gene for microbial transglutaminase from Streptoverticillium in Escherichia coli.
    Kawai M; Takehana S; Takagi H
    Biosci Biotechnol Biochem; 1997 May; 61(5):830-5. PubMed ID: 9178559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prostate transglutaminase (TGase-4, TGaseP) regulates the interaction of prostate cancer and vascular endothelial cells, a potential role for the ROCK pathway.
    Jiang WG; Ablin RJ; Kynaston HG; Mason MD
    Microvasc Res; 2009 Mar; 77(2):150-7. PubMed ID: 18983858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transglutaminase 2 expression in the salivary myoepithelial cells of mouse embryo.
    Lee SK; Kim YS; Lee YJ; Lee SS; Song IS; Park SC; Chi JG; Chung SI
    Arch Oral Biol; 2005 Mar; 50(3):301-8. PubMed ID: 15740708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-linked envelope-related markers for squamous differentiation in human lung cancer cell lines.
    Levitt ML; Gazdar AF; Oie HK; Schuller H; Thacher SM
    Cancer Res; 1990 Jan; 50(1):120-8. PubMed ID: 1967140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.